Cancer of the vulva is a relatively rare gynaecologic malignancy that represents less than 5% of gynaecologic cancer and is primarily seen in postmenopausal women. Like cervical cancer, the aetiology of vulvar cancer is prior infection with HPV. Patients with vulvar cancer complain of itching, pain, and local discomfort, often arising in the presence of atrophic changes of the vulvar epithelium. The treatment of vulvar cancer is surgical excision with good margins and possible dissection of one or both inguinal lymph node regions in advanced disease. Recurrent or unresectable vulvar cancer also can be treated with external beam radiation, often in combination with cisplatin in radiation sensitizing doses.

TestimonialsWhat They Are Saying

(Visited 1 times, 1 visits today)
About Genomic Medicine UK

Genomic Medicine UK is the home of comprehensive genomic testing in London. Our consultant medical doctors work tirelessly to provide the highest standards of medical laboratory testing for personalised medical treatments, genomic risk assessments for common diseases and genomic risk assessment for cancers at an affordable cost for everybody. We use state-of-the-art modern technologies of next-generation sequencing and DNA chip microarray to provide all of our patients and partner doctors with a reliable, evidence-based, thorough and valuable medical service.

Leave a Reply

Your email address will not be published. Required fields are marked *